ViroGates Valuation Multiples

ViroGates Overview

About ViroGates

ViroGates AS is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

Founded

2000

HQ

Employees

10

Website

virogates.com

Sectors

Medical DevicesHealthTech

Financials (FY)

Revenue: $1M

EBITDA: ($2M)

EV

$16M

Valuation Multiples

Multiples.vc

Start free trial

ViroGates Financials

ViroGates reported last fiscal year revenue of $1M and negative EBITDA of ($2M).

In the same fiscal year, ViroGates generated $1M in gross profit, ($2M) in EBITDA losses, and had net loss of ($2M).

ViroGates P&L

In the most recent fiscal year, ViroGates reported revenue of $1M and EBITDA of ($2M).

ViroGates expects next 12-month revenue of XXX and NTM EBITDA of XXX

ViroGates Stock Performance

ViroGates has current market cap of $17M, and enterprise value of $16M.

ViroGates' stock price is $1.83.

ViroGates Valuation Multiples

ViroGates trades at 11.9x EV/Revenue multiple, and (10.1x) EV/EBITDA.

ViroGates Financial Valuation Multiples

As of April 9, 2026, ViroGates has market cap of $17M and EV of $16M.

Equity research analysts estimate ViroGates' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

ViroGates has a P/E ratio of (10.6x).

ViroGates Margins & Growth Rates

ViroGates' revenue in the last fiscal year grew by 25%.

ViroGates' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.

ViroGates Public Comps

See public comps and valuation multiples for other Medical Devices comps.

ViroGates M&A Activity

ViroGates acquired XXX companies to date.

Last acquisition by ViroGates was on XXXXXXXX, XXXXX. ViroGates acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

ViroGates Investment Activity

ViroGates invested in XXX companies to date.

ViroGates made its latest investment on XXXXXXXX, XXXXX. ViroGates invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).